|
|
|
Insider
Information: |
Aryeh Jason |
Relationship: |
Director |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
401,047 |
|
Indirect Shares
|
890,847 |
|
|
Direct
Value |
$7,198,450 |
|
|
Indirect Value
|
$5,034,433 |
|
|
Total
Shares |
1,291,894 |
|
|
Total
Value |
$12,232,884 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ligand Pharmaceuticals Inc |
LGND |
Director |
2024-04-30 |
76,828 |
2024-04-30 |
56,619 |
Premium* |
|
Vaxart Inc |
VXRT |
Director |
2010-12-27 |
0 |
2011-03-15 |
131,783 |
Premium* |
|
Myrexis Inc |
MYRX |
Director |
|
0 |
2012-06-15 |
552,145 |
Premium* |
|
Novelion Therapeutics Inc |
NVLN |
Director |
2017-05-15 |
242,433 |
2017-05-15 |
150,300 |
Premium* |
|
Aralez Pharmaceuticals Inc. |
ARLZ |
Director |
2017-05-23 |
15,000 |
2017-05-23 |
0 |
Premium* |
|
Merrimack Pharmaceuticals Inc |
MACK |
See Explanation of Res... |
2019-07-16 |
3,802 |
2019-07-11 |
0 |
Premium* |
|
Orchestra BioMed Holdings Inc. |
OBIO |
Director |
2023-04-12 |
62,984 |
2023-01-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NVLN |
Novelion Therapeutics Inc |
Director |
|
2016-11-29 |
4 |
A |
$1.76 |
$1,999,999 |
D/D |
1,136,363 |
1,210,363 |
0 |
- |
|
ARLZ |
Aralez Pharmaceuticals In... |
Director |
|
2016-09-16 |
4 |
B |
$5.86 |
$1,732,664 |
I/I |
295,929 |
343,216 |
2.1 |
- |
|
NVLN |
Novelion Therapeutics Inc |
Director |
|
2016-11-29 |
4 |
A |
$0.00 |
$0 |
I/I |
290,024 |
82,765 |
0 |
- |
|
NVLN |
Novelion Therapeutics Inc |
Director |
|
2015-06-16 |
4 |
B |
$3.47 |
$999,360 |
I/I |
288,000 |
288,000 |
2.1 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2009-11-16 |
4 |
S |
$4.49 |
$1,151,308 |
I/I |
(255,276) |
977,374 |
0 |
- |
|
ARLZ |
Aralez Pharmaceuticals In... |
Director |
|
2017-05-22 |
4 |
S |
$1.42 |
$332,365 |
I/I |
(233,468) |
104,176 |
0 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2009-11-17 |
4 |
S |
$4.64 |
$941,934 |
I/I |
(185,909) |
791,465 |
0 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2010-03-11 |
4 |
AS |
$5.88 |
$1,062,335 |
I/I |
(180,700) |
387,420 |
0 |
- |
|
ARLZ |
Aralez Pharmaceuticals In... |
Director |
|
2017-05-23 |
4 |
S |
$1.41 |
$146,878 |
I/I |
(104,176) |
0 |
0 |
- |
|
MYRX |
Myrexis Inc |
Director |
|
2011-11-29 |
4 |
B |
$2.58 |
$236,660 |
I/I |
91,800 |
360,026 |
2.1 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2010-01-12 |
4 |
AS |
$5.49 |
$473,367 |
I/I |
(86,200) |
601,220 |
0 |
- |
|
MYRX |
Myrexis Inc |
Director |
|
2011-11-28 |
4 |
B |
$2.55 |
$165,512 |
I/I |
64,805 |
268,226 |
2.1 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2010-03-23 |
4 |
AS |
$6.25 |
$404,833 |
I/I |
(64,793) |
252,117 |
0 |
- |
|
MYRX |
Myrexis Inc |
Director |
|
2011-11-22 |
4 |
B |
$2.47 |
$132,639 |
I/I |
53,700 |
135,966 |
2.1 |
- |
|
OBIO |
Orchestra BioMed Holdings... |
Director |
|
2023-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
51,738 |
51,738 |
0 |
- |
|
ARLZ |
Aralez Pharmaceuticals In... |
Director |
|
2017-05-19 |
4 |
S |
$1.56 |
$79,558 |
I/I |
(51,041) |
337,644 |
0 |
- |
|
NVLN |
Novelion Therapeutics Inc |
Director |
|
2015-06-30 |
4 |
OE |
$3.27 |
$172,750 |
D/D |
50,000 |
74,000 |
0 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2010-01-08 |
4 |
AS |
$5.29 |
$244,171 |
I/I |
(46,157) |
687,420 |
0 |
- |
|
MYRX |
Myrexis Inc |
Director |
|
2011-12-01 |
4 |
B |
$2.65 |
$112,895 |
I/I |
42,618 |
402,644 |
2.1 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2010-01-06 |
4 |
AS |
$5.24 |
$222,154 |
I/I |
(42,365) |
737,020 |
0 |
- |
|
MYRX |
Myrexis Inc |
Director |
|
2011-11-25 |
4 |
B |
$2.51 |
$105,268 |
I/I |
41,956 |
203,421 |
2.1 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
INSIDER |
|
2014-02-18 |
144 |
NP |
$0.00 |
$3,091,664 |
/ |
40,320 |
0 |
|
- |
|
MYRX |
Myrexis Inc |
Director |
|
2011-12-05 |
4 |
B |
$2.75 |
$84,801 |
I/I |
30,792 |
461,036 |
2.1 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2010-03-22 |
4 |
AS |
$6.24 |
$177,902 |
I/I |
(28,510) |
316,910 |
0 |
- |
|
MYRX |
Myrexis Inc |
Director |
|
2011-12-02 |
4 |
B |
$2.69 |
$74,299 |
I/I |
27,600 |
430,244 |
2.1 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|